| Cited nodes | Nodes / Authors | GCS | LCS |
| 0 | 1 2001 ANNALS OF INTERNAL MEDICINE 135(4):306-307
Gomez-Ambrosi J; Fruhbeck G
Do resistin and resistin-like molecules also link obesity to inflammatory diseases? | 1 | 0
|
| 0 | 2 2001 ANNALS OF INTERNAL MEDICINE 135(11):1007-1008
Quesada-Gomez JM; Serrano-Alferez I
Nonhypoglycemic effects of thiazolidinediones | | 0
|
| 0 | 3 2001 BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM 15(3):293-308
Gloyn AL; McCarthy MI
The genetics of type 2 diabetes | | 0
|
| 1 | 4 2001 BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM 15(3):391-404
Boutin P; Froguel P
Genetics of human obesity | | 0
|
| 0 | 5 2001 BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS 944():350-361
Canaple L; Nurdin N; Angelova N; Hunkeler D; Desvergne B
Development of a coculture model of encapsulated cells | | 0
|
| 0 | 6 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 285(2):561-564
Nagaev I; Smith U
Insulin resistance and Type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle | 10 | 8
|
| 1 | 7 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 286(4):735-741
Moore GBT; Chapman H; Holder JC; Lister CA; Piercy V; Smith SA; Clapham JC
Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice | 5 | 5
|
| 1 | 8 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 287(2):435-439
Kitamura A; Nishizuka M; Tominaga K; Tsuchiya T; Nishihara T; Imagawa M
Expression of p68 RNA helicase is closely related to the early stage of adipocyte differentiation of mouse 3T3-L1 cells | | 0
|
| 5 | 9 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 288(4):1027-1031
Fasshauer M; Klein J; Neumann S; Eszlinger M; Paschke R
Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes | 1 | 1
|
| 5 | 10 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 289(2):564-567
Le Lay S; Boucher J; Rey A; Castan-Laurell I; Krief S; Ferre P; Valet P; Dugail I
Decreased resistin expression in mice with different sensitivities to a high-fat diet | | 0
|
| 0 | 11 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 289(5):1188-1191
Borst SE; Hennessy M
beta-3 adrenergic agonist restores skeletal muscle insulin responsiveness in Sprague-dawley rats | | 0
|
| 4 | 12 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 289(5):1328-1333
Juan CC; Au LC; Fang VS; Kang SF; Ko YH; Kuo SF; Hsu YP; Kwok CF; Ho LT
Suppressed gene expression of adipocyte resistin in an insulin- resistant rat model probably by elevated free fatty acids | | 0
|
| 0 | 13 2001 BIOCHEMICAL JOURNAL 359():393-402
Albrektsen T; Richter HE; Clausen JT; Fleckner J
Identification of a novel integral plasma membrane protein induced during adipocyte differentiation | 1 | 0
|
| 1 | 14 2001 BIOCHEMICAL SOCIETY TRANSACTIONS 29():785-791
Dulloo AG; Samec S; Seydoux J
Uncoupling protein 3 and fatty acid metabolism | | 0
|
| 0 | 15 2001 BRITISH JOURNAL OF NUTRITION 86(2):123-139
Dulloo AG; Samec S
Uncoupling proteins: their roles in adaptive thermogenesis and substrate metabolism reconsidered | 6 | 1
|
| 0 | 16 2001 BRITISH MEDICAL BULLETIN 60():51-67
Prentice AM
Obesity and its potential mechanistic basis | | 0
|
| 0 | 17 2001 CELL 104(4):517-529
Saltiel AR
New perspectives into the molecular pathogenesis and treatment of Type 2 diabetes | 26 | 5
|
| 0 | 18 2001 CLINICAL ENDOCRINOLOGY 55(4):437-438
Vidal-Puig A; O'Rahilly S
Resistin: a new link between obesity and insulin resistance? | 1 | 0
|
| 1 | 19 2001 CLINICAL GENETICS 60(4):243-254
Busch CP; Hegele RA
Genetic determinants of type 2 diabetes mellitus | 1 | 0
|
| 1 | 20 2001 CURRENT SCIENCE 80(11):1369-1371
Ehtesham NZ
Molecular link between diabetes and obesity: The resistin story | | 0
|
| 0 | 21 2001 DIABETES 50(9):2061-2068
Marti L; Abella A; Carpene C; Palacin M; Testar X; Zorzano A
Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats | | 0
|
| 0 | 22 2001 DIABETES 50(9):2094-2099
Maeda N; Takahashi M; Funahashi T; Kihara S; Nishizawa H; Kishida K; Nagaretani H; Matsuda M; Komuro R; Ouchi N; Kuriyama H; Hotta K; Nakamura T; Shimomura I; Matsuzawa Y
PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein | 12 | 4
|
| 2 | 23 2001 DIABETES 50(10):2199-2202
Savage DB; Sewter CP; Klenk ES; Segal DG; Vidal-Puig A; Considine RV; O'Rahilly S
Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans | 9 | 8
|
| 0 | 24 2001 DIABETES 50(12):2809-2814
Guerre-Millo M; Rouault C; Poulain P; Andre J; Poitout V; Peters JM; Gonzalez FJ; Fruchart JC; Reach G; Staels B
PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance | | 0
|
| 0 | 25 2001 DIABETES & METABOLISM 27(2):261-270
Ziegler O; Quilliot D; Guerci B; Drouin P
Macronutrients, fat mass, fatty acid flux and insulin sensitivity | | 0
|
| 0 | 26 2001 DIABETOLOGIA 44(12):2210-2219
Miyazaki Y; Glass L; Triplitt C; Matsuda M; Cusi K; Mahankali A; Mahankali S; Mandarino LJ; DeFronzo RA
Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients | | 0
|
| 0 | 27 2001 DOMESTIC ANIMAL ENDOCRINOLOGY 21(1):25-37
Kushibiki S; Hodate K; Shingu H; Ueda Y; Shinoda M; Mori Y; Itoh T; Yokomizo Y
Insulin resistance induced in dairy steers by tumor necrosis factor alpha is partially reversed by 2,4-thiazolidinedione | | 0
|
| 0 | 28 2001 DOMESTIC ANIMAL ENDOCRINOLOGY 21(4):197-214
Vernon RG; Denis RGP; Sorensen A
Signals of adiposity | | 0
|
| 0 | 29 2001 ENDOCRINOLOGY 142(11):4806-4812
Sweeney G; Keen J; Somwar R; Konrad D; Garg R; Klip A
High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in L6 rat skeletal muscle cells | 2 | 0
|
| 0 | 30 2001 ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA 30(4):801-+
Boden G
Pathogenesis of type 2 diabetes - Insulin resistance | | 0
|
| 0 | 31 2001 EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 109():S265-S287
Raptis SA; Dimitriadis GD
Oral hypoglycemic agents: insulin secretagogues, alpha- glucosidase inhibitors and insulin sensitizers | | 0
|
| 1 | 32 2001 EXPERIMENTAL BIOLOGY AND MEDICINE 226(11):963-977
Havel PJ
Peripheral signals conveying metabolic information to the brain: Short-term and long-term regulation of food intake and energy homeostasis | 2 | 1
|
| 1 | 33 2001 EXPERIMENTAL BIOLOGY AND MEDICINE 226(11):997-1002
Gregoire FM
Adipocyte differentiation: From fibroblast to endocrine cell | 2 | 0
|
| 0 | 34 2001 FASEB JOURNAL 15(11):1996-2006
Fruhbeck G; Gomez-Ambrosi J
Rationale for the existence of additional adipostatic hormones | | 0
|
| 1 | 35 2001 FEBS LETTERS 500(1-2):60-63
Fasshauer M; Kein J; Neumann S; Eszlinger M; Paschke R
Isoproterenol inhibits resistin gene expression through a G(S)- protein-coupled pathway in 3T3-L1 adipocytes | 10 | 10
|
| 3 | 36 2001 FEBS LETTERS 507(1):105-108
Haugen F; Jorgensen A; Drevon CA; Trayhurn P
Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes | 2 | 2
|
| 2 | 37 2001 FEBS LETTERS 507(2):142-146
Fasshauer M; Klein J; Neumann S; Eszlinger M; Paschke R
Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes | 1 | 1
|
| 2 | 38 2001 FEBS LETTERS 507(2):147-150
Ling C; Kindblom J; Wennbo H; Billig H
Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels | 2 | 2
|
| 0 | 39 2001 HORMONE RESEARCH 55():3-13
Stumvoll M; Haring H
Insulin resistance and insulin sensitizers | | 0
|
| 0 | 40 2001 HOSPITAL PRACTICE 36(9):29-36
Goldfine AB
Type 2 diabetes: New drugs, new perspectives | | 0
|
| 0 | 41 2001 INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE 5(3):159-167
Gonzalez A; McLachlan S; Keaney F
Anabolic steroid misuse: How much should we know? | | 0
|
| 0 | 42 2001 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 286(3):327-334
Pradhan AD; Manson JE; Rifai N; Buring JE; Ridker PM
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus | 14 | 0
|
| 0 | 43 2001 JOURNAL OF BIOLOGICAL CHEMISTRY 276(14):11252-11256
Kim KH; Lee K; Moon YS; Sul HS
A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation | 29 | 26
|
| 2 | 44 2001 JOURNAL OF BIOLOGICAL CHEMISTRY 276(28):25651-25653
Way JM; Gorgun CZ; Tong Q; Uysal KT; Brown KK; Harrington WW; Oliver WR; Willson TM; Kliewer SA; Hotamisligil GS
Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists | 23 | 22
|
| 1 | 45 2001 JOURNAL OF BIOLOGICAL CHEMISTRY 276(28):25970-25973
Banerjee RR; Lazar MA
Dimerization of resistin and resistin-like molecules is determined by a single cysteine | 3 | 3
|
| 1 | 46 2001 JOURNAL OF BIOLOGICAL CHEMISTRY 276(32):29625-29627
Nishizuka M; Honda K; Tsuchiya T; Nishihara T; Imagawa M
RGS2 promotes adipocyte differentiation in the presence of ligand for peroxisome proliferator-activated receptor gamma | 1 | 0
|
| 0 | 47 2001 JOURNAL OF BIOLOGICAL CHEMISTRY 276(38):35990-35994
Roh C; Roduit R; Thorens B; Fried S; Kandror KV
Lipoprotein lipase and leptin are accumulated in different secretory compartments in rat adipocytes | 3 | 0
|
| 2 | 48 2001 JOURNAL OF BIOLOGICAL CHEMISTRY 276(41):37731-37734
Rosen ED; Spiegelman BM
PPAR gamma: a nuclear regulator of metabolism, differentiation, and cell growth | 8 | 1
|
| 0 | 49 2001 JOURNAL OF CARDIOVASCULAR RISK 8(4):203-210
Marx N; Libby P; Plutzky J
Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk? | 1 | 0
|
| 0 | 50 2001 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 86(9):4047-4058
Kahn SE
Clinical review 135 - The importance of beta-cell failure in the development and progression of type 2 diabetes | 3 | 0
|
| 1 | 51 2001 JOURNAL OF CLINICAL INVESTIGATION 108(7):963-964
Schwartz MW
Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity | 2 | 1
|
| 0 | 52 2001 JOURNAL OF CLINICAL INVESTIGATION 108(7):1001-1013
Yamauchi T; Waki H; Kamon J; Murakami K; Motojima K; Komeda K; Miki H; Kubota N; Terauchi Y; Tsuchida A; Tsuboyama-Kasaoka N; Yamauchi N; Ide T; Hori W; Kato S; Fukayama M; Akanuma Y; Ezaki O; Itai A; Nagai R; Kimura S; Tobe K; Kagechika H; Shudo K; Kadowaki T
Inhibition of RXR and PPAR gamma ameliorates diet-induced obesity and type 2 diabetes | 5 | 1
|
| 1 | 53 2001 JOURNAL OF CLINICAL INVESTIGATION 108(11):1723-1724
Netea MG; Tack CJ; Netten PM; Lutterman JA; Van der Meer JWM
The effect of salicylates on insulin sensitivity | 1 | 0
|
| 2 | 54 2001 JOURNAL OF CLINICAL INVESTIGATION 108(12):1875-1881
Combs TP; Berg AH; Obici S; Scherer PE; Rossetti L
Endogenous glucose production is inhibited by the adipose- derived protein Acrp30 | | 0
|
| 0 | 55 2001 JOURNAL OF CLINICAL PSYCHIATRY 62():15-26
Haupt DW; Newcomer JW
Hyperglycemia and antipsychotic medications | | 0
|
| 0 | 56 2001 JOURNAL OF HUMAN GENETICS 46(9):553-555
Cao HN; Hegele RA
Single nucleotide polymorphisms of the resistin (RSTN) gene | 2 | 2
|
| 0 | 57 2001 JOURNAL OF INTERNAL MEDICINE 250(2):105-120
Groop L; Orho-Melander M
The dysmetabolic syndrome | 2 | 0
|
| 0 | 58 2001 JOURNAL OF NUTRITION 131(8):2078-2081
Nadler ST; Attie AD
Please pass the chips: Genomic insights into obesity and diabetes | 4 | 1
|
| 0 | 59 2001 JOURNAL OF NUTRITION 131(9):2242-2247
Liu F; Kim JK; Li YH; Liu XQ; Li J; Chen XH
An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation- inhibitory activities in 3T3-L1 cells | | 0
|
| 0 | 60 2001 JOURNAL OF PATHOLOGY 195(1):87-96
Frantz GD; Pham TQ; Peale FV; Hillan KJ
Detection of novel gene expression in paraffin-embedded tissues by isotopic in situ hybridization in tissue microarrays | 4 | 0
|
| 3 | 61 2001 JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY 57(3):287-288
Martinez JA; Margareto J; Marti A; Milagro FI; Larrarte E; Aliaga MJM
Resistin overexpression is induced by a beta 3 adrenergic agonist in diet-related overweightness | | 0
|
| 0 | 62 2001 KIDNEY INTERNATIONAL 60(1):14-30
Guan YF; Breyer MD
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease | 5 | 0
|
| 0 | 63 2001 MECHANISMS OF AGEING AND DEVELOPMENT 122(14):1565-1576
Gabriely I; Barzilai N
The role of fat cell derived peptides in age-related metabolic alterations | | 0
|
| 0 | 64 2001 MEDICAL JOURNAL OF AUSTRALIA 175(2):65-66
Gan SK; Chisholm DJ
The type 2 diabetes epidemic: a hidden menace | 1 | 0
|
| 0 | 65 2001 MEDICINAL CHEMISTRY RESEARCH 10(7-8):480-492
McCormack JG
New therapeutic approaches for diabetes | | 0
|
| 0 | 66 2001 METABOLISM-CLINICAL AND EXPERIMENTAL 50(12):1499-1504
Sims EAH
Are there persons who are obese, but metabolically healthy? | 1 | 0
|
| 0 | 67 2001 MOLECULAR ENDOCRINOLOGY 15(11):1864-1869
Sykiotis GP; Papavassiliou AG
Serine phosphorylation of insulin receptor substrate-1: A novel target for the reversal of insulin resistance | | 0
|
| 0 | 68 2001 MOLECULAR GENETICS AND METABOLISM 74(1-2):98-104
Eurlings PMH; van der Kallen CJH; Geurts JMW; van Greevenbroek MMJ; de Bruin TWA
Genetic dissection of familial combined hyperlipidemia | | 0
|
| 0 | 69 2001 NATURE 409(6818):292-293
Flier JS
Diabetes - The missing link with obesity? | 8 | 5
|
| 0 | 70 2001 NATURE 409(6821):672-673
Birnbaum MJ
Diabetes - Dialogue between muscle and fat | 1 | 0
|
| 2 | 71 2001 NATURE 414(6865):821-827
Moller DE
New drug targets for type 2 diabetes and the metabolic syndrome | | 0
|
| 0 | 72 2001 NATURE MEDICINE 7(8):941-946
Yamauchi T; Kamon J; Waki H; Terauchi Y; Kubota N; Hara K; Mori Y; Ide T; Murakami K; Tsuboyama-Kasaoka N; Ezaki O; Akanuma Y; Gavrilova O; Vinson C; Reitman ML; Kagechika H; Shudo K; Yoda M; Nakano Y; Tobe K; Nagai R; Kimura S; Tomita M; Froguel P; Kadowaki T
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | 37 | 20
|
| 0 | 73 2001 NEUROBIOLOGY OF AGING 22(6):937-944
Landreth GE; Heneka MT
Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease | | 0
|
| 2 | 74 2001 NEW ENGLAND JOURNAL OF MEDICINE 345(18):1345-1346
Shuldiner AR; Yang RZ; Gong DW
Resistin, obesity, and insulin resistance - The emerging role of the adipocyte as an endocrine organ. | 2 | 1
|
| 0 | 75 2001 NUTRITION 17(11-12):953-966
Das UN
Is obesity an inflammatory condition? | 1 | 0
|
| 0 | 76 2001 OBESITY RESEARCH 9(9):535-543
Furler SM; Poynten AM; Kriketos AD; Lowy AJ; Ellis BA; Maclean EL; Courtenay BG; Kraegen EW; Campbell LV; Chisholm DJ
Independent influences of central fat and skeletal muscle lipids on insulin sensitivity | | 0
|
| 0 | 77 2001 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98(13):7522-7527
Kim JK; Fillmore JJ; Chen Y; Yu CL; Moore IK; Pypaert M; Lutz EP; Kako Y; Velez-Carrasco W; Goldberg IJ; Breslow JL; Shulman GI
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance | 13 | 4
|
| 0 | 78 2001 PROCEEDINGS OF THE NUTRITION SOCIETY 60(3):329-339
Trayhurn P; Beattie JH
Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ | 3 | 2
|
| 1 | 79 2001 PROCEEDINGS OF THE NUTRITION SOCIETY 60(3):357-364
Rayner DV
The sympathetic nervous system in white adipose tissue regulation | 1 | 0
|
| 0 | 80 2001 REVISTA DE INVESTIGACION CLINICA 53(3):209-211
Fernandez-Mejia C
A new panorama for understanding the molecular links between obesity and type 2 diabetes | | 0
|
| 0 | 81 2001 SCIENCE 291(5513):2558-2559
Ruderman N; Flier JS
Cell biology - Chewing the fat - ACC and energy balance | | 0
|
| 1 | 82 2001 SCIENCE 294(5549):2166-2170
Masuzaki H; Paterson J; Shinyama H; Morton NM; Mullins JJ; Seckl JR; Flier JS
A transgenic model of visceral obesity and the metabolic syndrome | 3 | 1
|
| 0 | 83 2001 SURGICAL CLINICS OF NORTH AMERICA 81(5):1039-+
Kral JG
Morbidity of severe obesity | | 0
|
| 0 | 84 2001 TRENDS IN BIOTECHNOLOGY 19(10):S55-S60
Schrader M; Schulz-Knappe P
Peptidomics technologies for human body fluids | 1 | 0
|
| 1 | 85 2001 TRENDS IN CELL BIOLOGY 11(11):437-441
Zick Y
Insulin resistance: a phosphorylation-based uncoupling of insulin signaling | 2 | 0
|
| 0 | 86 2001 TRENDS IN MOLECULAR MEDICINE 7(9):395-400
Sporn MB; Suh N; Mangelsdorf DJ
Prospects for prevention and treatment of cancer with selective PPAR gamma modulators (SPARMs) | 4 | 0
|
| 0 | 87 2001 VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE 31(5):881-+
Rand JS; Martin GJ
Management of feline diabetes mellitus | | 0
|
| 0 | 88 2001 WESTERN JOURNAL OF MEDICINE 175(4):223-224
Lighthall D
The poor health of farm workers - Rates of obesity, hypertension, and high cholesterol levels are high, but most have no health insurance | | 0
|
| 0 | 89 2002 AMERICAN JOURNAL OF EPIDEMIOLOGY 155(1):57-64
Ford ES
Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults | | 0
|
| 1 | 90 2002 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 282(1):E38-E45
Wu CD; Okar DA; Newgard CB; Lange AJ
Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes | | 0
|
| 2 | 91 2002 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 282(3):E626-E633
Levy JR; Davenport B; Clore JN; Stevens W
Lipid metabolism and resistin gene expression in insulin- resistant Fischer 344 rats | | 0
|
| 0 | 92 2002 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 282(4):E834-E842
Burcelin M; Crivelli V; Dacosta A; Roy-Tirelli A; Thorens B
Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet | | 0
|
| 0 | 93 2002 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 282(6):E1334-E1341
Li JP; Yu XX; Pan WT; Unger RH
Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity | | 0
|
| 0 | 94 2002 ANNUAL REVIEW OF MEDICINE 53():409-435
Berger J; Moller DE
The mechanisms of action of PPARs | | 0
|
| 0 | 95 2002 ARCHIVES OF GENERAL PSYCHIATRY 59(4):337-345
Newcomer JW; Haupt DW; Fucetola R; Melson AK; Schweiger JA; Cooper BP; Selke G
Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia | | 0
|
| 3 | 96 2002 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 290(3):1084-1089
Fasshauer M; Klein J; Neumann S; Eszlinger M; Paschke R
Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes | | 0
|
| 0 | 97 2002 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 290(4):1282-1288
Aoki K; Sun YJ; Aoki S; Wada K; Wada E
Cloning, expression, and mapping of a gene that is upregulated in adipose tissue of mice deficient in bombesin receptor subtype-3 | | 0
|
| 0 | 98 2002 CALCIFIED TISSUE INTERNATIONAL 70(4):305-311
Mathey J; Horcajada-Molteni MN; Chanteranne B; Picherit C; Puel C; Lebecque P; Cubizoles C; Davicco MJ; Coxam V; Barlet JP
Bone mass in obese diabetic Zucker rats: Influence of treadmill running | | 0
|
| 0 | 99 2002 CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH 63(1):20-32
Sievenpiper JL; Jenkins AL; Whitman DL; Vuksan V
Insulin resistance: Concepts, controversies, and the role of nutrition | | 0
|
| 1 | 100 2002 CURRENT DRUG TARGETS 3(3):203-221
Moneva MH; Dagogo-Jack S
Multiple drug targets in the management of type 2 diabetes | | 0
|
| 1 | 101 2002 CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE 5(1):11-17
Kinney JM
Insulin resistance in the elderly-the focus enlarges | | 0
|
| 7 | 102 2002 CURRENT OPINION IN LIPIDOLOGY 13(1):51-59
Havel PJ
Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin | | 0
|
| 1 | 103 2002 DIABETES 51(1):37-41
Stumvoll M; Tschritter O; Fritsche A; Staiger H; Renn W; Weisser M; Machicao F; Haring H
Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity - Interaction with family history of type 2 diabetes | 1 | 0
|
| 2 | 104 2002 DIABETES 51(3):797-802
Mayerson AB; Hundal RS; Dufour S; Lebon V; Befroy D; Cline GW; Enocksson S; Inzucchi SE; Shulman GI; Petersen KF
The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes | 1 | 0
|
| 3 | 105 2002 DIABETES 51(3):860-862
Sentinelli F; Romeo S; Arca M; Filippi E; Leonetti F; Banchieri M; Di Mario U; Baroni MG
Human resistin gene, obesity, and type 2 diabetes - Mutation analysis and population study | | 0
|
| 1 | 106 2002 DIABETES 51(3):863-866
Osawa H; Onuma H; Murakami A; Ochi M; Nishimiya T; Kato K; Shimizu I; Fujii Y; Ohashi J; Makino H
Systematic search for single nucleotide polymorphisms in the resistin gene - The absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes | 1 | 0
|
| 3 | 107 2002 DIABETES 51(4):1005-1015
Cnop M; Landchild MJ; Vidal J; Havel PJ; Knowles NG; Carr DR; Wang F; Hall RL; Boyko EJ; Retzlaff BM; Walden CE; Knopp RH; Kahn SE
The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations - Distinct metabolic effects of two fat compartments | | 0
|
| 9 | 108 2002 DIABETES 51(5):1629-1634
Engert JC; Vohl MC; Williams SM; Lepage P; Loredo-Osti JC; Faith J; Dore C; Renaud Y; Burtt NP; Villeneuve A; Hirschhorn JN; Altshuler D; Groop LC; Despres JP; Gaudet D; Hudson TJ
5 ' flanking variants of resistin are associated with obesity | | 0
|
| 0 | 109 2002 DIABETES CARE 25(3):425-430
Parker B; Luscombe N; Noakes M; Clifton P
Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes | | 0
|
| 0 | 110 2002 DOMESTIC ANIMAL ENDOCRINOLOGY 22(1):1-23
Houseknecht KL; Cole BM; Steele PJ
Peroxisome proliferator-activated receptor gamma (PPAR gamma) and its ligands: A review | | 0
|
| 0 | 111 2002 DRUG NEWS & PERSPECTIVES 15(1):5-9
Gouni-Berthold I; Sachinidis A
Inhibition of the low density lipoprotein-induced vascular smooth muscle cell growth by PPARy ligands | | 0
|
| 1 | 112 2002 DRUGS 62(6):915-944
Fernandez-Lopez JA; Remesar X; Foz M; Alemany M
Pharmacological approaches for the treatment of obesity | | 0
|
| 2 | 113 2002 ENDOCRINE REVIEWS 23(2):201-229
Lewis GF; Carpentier A; Adeli K; Giacca A
Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes | | 0
|
| 0 | 114 2002 ENDOCRINOLOGY 143(1):185-190
Lee HM; Wang GY; Englander EW; Kojima M; Greeley GH
Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: Enteric distribution, ontogeny, influence of endocrine, and dietary manipulations | 1 | 0
|
| 1 | 115 2002 ENDOCRINOLOGY 143(4):1502-1511
Xu HY; Hirosumi J; Uysal KT; Guler AD; Hotamisligil GS
Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance | | 0
|
| 6 | 116 2002 ENDOCRINOLOGY 143(6):2445-2448
Delhanty PJD; Mesotten D; McDougall F; Baxter RC
Growth hormone rapidly induces resistin gene expression in white adipose tissue of spontaneous dwarf (SDR) rats | | 0
|
| 0 | 117 2002 ERNAHRUNGS-UMSCHAU 49(2):A4-A7
Metzner C
Sweeteners and nutritional medicine | | 0
|
| 2 | 118 2002 EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 32():24-34
Greenberg AS; McDaniel ML
Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes | 3 | 1
|
| 1 | 119 2002 EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 32():46-53
Gerich JE
Redefining the clinical management of type 2 diabetes: matching therapy to pathophysiology | 2 | 1
|
| 1 | 120 2002 EUROPEAN JOURNAL OF PHARMACOLOGY 440(2-3):223-234
Kersten S
Peroxisome proliferator activated receptors and obesity | | 0
|
| 1 | 121 2002 GENES & DEVELOPMENT 16(8):908-912
Sakaue H; Konishi M; Ogawa W; Asaki T; Mori T; Yamasaki M; Takata M; Ueno H; Kato S; Kasuga M; Itoh N
Requirement of fibroblast growth factor 10 in development of white adipose tissue | | 0
|
| 0 | 122 2002 GYNAKOLOGE 35(1):48-63
Geisthovel F
Functional hyperandrogenism (so-called "polycystic ovary syndrome"). New aspects of classification, etiology, diagnosis, and therapy | | 0
|
| 0 | 123 2002 HYPERTENSION RESEARCH 25(1):25-29
Yamamoto J; Kageyama S; Nemoto M; Sasaki T; Sakurai T; Ishibashi K; Mimura A; Yokota K; Tajima N
PPAR gamma 2 Pro12Ala polymorphism and insulin resistance in Japanese hypertensive patients | | 0
|
| 0 | 124 2002 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 287(3):360-372
Inzucchi SE
Oral antihyperglycemic therapy for type 2 diabetes - Scientific review | 7 | 0
|
| 0 | 125 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(3):1941-1948
Schinner S; Dellas C; Schroder M; Heinlein CA; Chang CS; Fischer J; Knepel W
Repression of glucagon gene transcription by peroxisome proliferator-activated receptor gamma through inhibition of Pax6 transcriptional activity | | 0
|
| 4 | 126 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(15):12503-12506
Forman BM
The antidiabetic agent LG100754 sensitizes cells to low concentrations of peroxisome proliferator-activated receptor gamma ligands | | 0
|
| 0 | 127 2002 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 87(4):1894-1897
Menzaghi C; Plengvidhya N; Ma XW; Warram JH; Shoelson SE; Doria A
Genetic variability in insulin action inhibitor Ikk beta (IKBKB) does not play a major role in the development of type 2 diabetes | | 0
|
| 2 | 128 2002 JOURNAL OF CLINICAL INVESTIGATION 109(8):1049-1055
Chen HC; Smith SJ; Ladha Z; Jensen DR; Ferreira LD; Pulawa LK; McGuire JG; Pitas RE; Eckel RH; Farese RV
Increased insulin and leptin sensitivity in mice lacking acyl CoA : diacylglycerol acyltransferase 1 | | 0
|
| 5 | 129 2002 JOURNAL OF LIPID RESEARCH 43(2):177-186
Walczak R; Tontonoz P
PPARadigms and PPARadoxes: expanding roles for PPAR gamma in the control of lipid metabolism | | 0
|
| 0 | 130 2002 JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM 15(4):343-361
Pomilio M; Mohn A; Verrotti A; Chiarelli F
Endothelial dysfunction in children with type 1 diabetes mellitus | | 0
|
| 0 | 131 2002 JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES 57(1):M2-M6
Morley JE
Drugs, aging, and the future | | 0
|
| 1 | 132 2002 LANCET 359(9300):46-47
McTernan CL; McTernan PG; Harte AL; Levick PL; Barnett AH; Kumar S
Resistin, central obesity, and type 2 diabetes | 2 | 2
|
| 1 | 133 2002 MEDICINA CLINICA 118(16):619-621
Escofet FJS; Martinez GR
The irresistible ascent of the adipose cell | | 0
|
| 4 | 134 2002 MOLECULAR ENDOCRINOLOGY 16(5):1040-1048
Li Y; Lazar MA
Differential gene regulation by PPAR gamma agonist and constitutively active PPAR gamma 2 | | 0
|
| 3 | 135 2002 NUTRITION REVIEWS 60(5):148-151
Wolf G
Glucocorticoids in adipocytes stimulate visceral obesity | | 0
|
| 4 | 136 2002 OBESITY RESEARCH 10(1):1-5
Jonke J; Engeli S; Gorzelniak K; Luft FC; Sharma AM
Resistin gene expression in human adipocytes is not related to insulin resistance. | | 0
|
| 6 | 137 2002 OBESITY RESEARCH 10(1):61-62
Smith U
Resistin - Resistant to defining its role | | 0
|
| 1 | 138 2002 PLACENTA 23():S80-S86
Sagawa N; Yura S; Itoh H; Mise H; Kakui K; Korita D; Takemura M; Nuamah MA; Ogawa Y; Masuzaki H; Nakao K; Fujii S
Role of leptin in pregnancy - A review | | 0
|
| 0 | 139 2002 SOUTH AFRICAN JOURNAL OF SCIENCE 98(1-2):15-18
Manchester KL
The action of insulin: where have we got to? | | 0
|
| 2 | 140 2002 TRENDS IN ENDOCRINOLOGY AND METABOLISM 13(1):5-11
MacDougald OA; Mandrup S
Adipogenesis: forces that tip the scales | 1 | 1
|
| 9 | 141 2002 TRENDS IN ENDOCRINOLOGY AND METABOLISM 13(1):18-23
Steppan CM; Lazar MA
Resistin and obesity-associated insulin resistance | | 0
|